
CLAIM MORE OF YOUR LIFE WITH FRUZAQLA®
In a clinical study, people with mCRC lived a median of 7.4 months with FRUZAQLA + BSC* vs 4.8 months with placebo (sugar pill) + BSC.
*BSC=best supportive care.
What is FRUZAQLA® (fruquintinib)?
For adults with metastatic colorectal cancer (mCRC), FRUZAQLA is an innovative and convenient oral treatment with proven survival results that can be taken after chemotherapy and other anti-cancer medications.
FRUZAQLA is a targeted therapy for people living with previously treated mCRC. FRUZAQLA is not chemotherapy.

Which statement best describes you? Select an option below to learn more:
Which statement best describes you?
†In a clinical study, people with mCRC lived a median of 7.4 months with FRUZAQLA + BSC vs 4.8 months with placebo (sugar pill) + BSC (a 2.6 month improvement).
Side effects with FRUZAQLA
Explore the potential common side effects while taking FRUZAQLA.
Pay as little as $0 per prescription. Terms and conditions apply‡
With Takeda Here2Assist, we’re here to help with coverage, financial, and educational resource needs.
‡By enrolling in the Takeda Oncology Co-pay Assistance Program (the “Program”), you acknowledge that you currently meet the eligibility criteria and will comply with the following terms and conditions:
You must be at least 18 years old, a resident of the United States or a US Territory, and have commercial (private) prescription insurance that does not cover the entire cost of the medication. The Program is not valid for patients whose prescription claims are eligible to be reimbursed, in whole or in part, by any state or federal government program, including, but not limited to, Medicare, Medicare Advantage, Medigap, Medicaid, Department of Defense (DoD), Veterans Affairs (VA), TRICARE, Puerto Rico Government Insurance, or any state patient or pharmaceutical assistance program. Patients who become eligible for or start using government insurance will no longer be eligible for the Program. The Program is not valid if the entire cost of your prescription is reimbursable by a private insurance plan or other private health or pharmacy benefit programs. You are responsible for reporting receipt of Program assistance to any insurer, health plan, or other third party who pays for or reimburses any part of the medication cost, as may be required. You agree that you will not submit the cost of any portion of the product dispensed pursuant to this Program to a federal or state healthcare program (including, but not limited to, Medicare, Medicare Advantage, Medicaid, TRICARE, VA, DOD, etc.), for purposes of counting it toward your out-of-pocket expenses, and to notify Takeda Oncology Here2Assist® if you become eligible for a federal or state healthcare program. This Program is not conditioned on any past, present or future purchase of any Takeda product, including refills. This Program is valid for 12 months, and your co-pay card may be renewed every 12 months, subject to continued eligibility. This offer is not valid with any other program, discount, or offer involving your prescribed Takeda Oncology medication. This offer may be rescinded, revoked, or amended without notice. No reproductions. This offer is void where prohibited by law, taxed, or restricted. Limit one offer per purchase. No income requirements or membership fees. This Program is not health insurance. Cash value of 1/100 of 1¢. For questions about this offer, please contact the Takeda Oncology Co-Pay Assistance Program, a patient support service of Takeda Oncology Here2Assist, at 1-844-817-6468, Option 2, Monday-Friday, 8AM-8PM ET.